Alzheimer Disease l: Introduction
RNA Editing
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Exon Recombination
Receptor-mediated Endocytosis
Aquaporins
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 7, 2026

Optimized Negative Staining: a High-throughput Protocol for Examining Small and Asymmetric Protein Structure by Electron Microscopy
Published on: August 15, 2014
1Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, 63110.
Apolipoprotein E4 (apoE4) increases Alzheimer's risk due to a single amino acid change. Understanding structural differences between apoE3 and apoE4 is key to developing treatments.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: